In conclusion, we present here the first proof-of-principle data for stable, functional 5′trans-splicing for RDEB patients, overcoming limitations of cDNA gene therapy for the large COL7A1 gene. Here, COL7A1 is linked to recessive dystrophic epidermolysis bullosa.